Capstone Investment Advisors LLC Makes New Investment in Addus HomeCare Corporation $ADUS

Capstone Investment Advisors LLC acquired a new position in Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 6,856 shares of the company’s stock, valued at approximately $689,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Addus HomeCare during the 2nd quarter valued at about $344,153,000. Bank of America Corp DE bought a new stake in Addus HomeCare in the second quarter worth approximately $35,527,000. TimesSquare Capital Management LLC acquired a new position in Addus HomeCare in the second quarter valued at approximately $31,502,000. Capital Research Global Investors boosted its holdings in shares of Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after buying an additional 268,192 shares in the last quarter. Finally, Punch & Associates Investment Management Inc. bought a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $20,911,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $115.55 on Friday. The business’s fifty day simple moving average is $111.95 and its 200 day simple moving average is $102.96. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The firm has a market capitalization of $2.16 billion, a P/E ratio of 20.27, a price-to-earnings-growth ratio of 1.58 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The firm had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the prior year, the company earned $1.49 EPS. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, analysts anticipate that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of analyst reports. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Barclays raised their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. Finally, Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $130.88.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.